Presidential Immunity and Mandamus Limits in COVID-19 Vaccine Procurement Cases

The Supreme Court has long held that a sitting President cannot be sued, and that the writ of mandamus only compels ministerial duties—not discretionary acts. In Nepomuceno v. President Duterte (May 11, 2021), the Court applied both principles to dismiss a petition seeking to compel the government to conduct clinical trials and public bidding for COVID-19 vaccines. The ruling clarifies the boundaries of presidential immunity and the proper scope of mandamus, especially during a public health emergency.

The Facts of the Case

Former Boac, Marinduque Mayor Pedrito Nepomuceno filed a petition for mandamus against President Rodrigo Duterte, Health Secretary Francisco Duque, the Inter-Agency Task Force on Emerging Infectious Diseases, and Gen. Carlito Galvez Jr. The petitioner sought to compel respondents to observe FDA rules on drug acquisition and procurement, particularly requiring clinical trials before the Sinovac COVID-19 vaccine could be used in the Philippines. He also asked the Court to order a cease-and-desist against the vaccine's purchase and use, and to require all COVID-19 vaccines to undergo local trials before emergency or regular use.

The Issue

The central question was whether the writ of mandamus could compel government officials to conduct clinical trials and public bidding for COVID-19 vaccines, and whether the President could be sued at all in such a proceeding.

Presidential Immunity from Suit

The Court first ruled that President Duterte must be dropped as a respondent. Under settled jurisprudence, the President cannot be sued during tenure, regardless of the nature of the suit. This immunity applies whether the acts complained of are personal or official. The rationale, as explained in De Lima v. President Duterte and earlier cases like Soliven v. Makasiar, is to free the Chief Executive from distractions that would impair the performance of presidential duties. While the 1987 Constitution does not expressly state this immunity, the framers considered it understood in existing jurisprudence. The only proceeding where a sitting President may be involved in litigation is impeachment.

Mandamus Requires a Ministerial Duty

The Court then dismissed the petition on its merits. Under Section 3, Rule 65 of the Revised Rules of Court, mandamus lies only when a respondent unlawfully neglects a duty specifically enjoined by law, or unlawfully excludes another from a right to which the latter is entitled. Critically, the duty must be ministerial—one performed in a prescribed manner without the exercise of judgment—not discretionary.

The petitioner failed to identify any law imposing a ministerial duty to conduct clinical trials or public bidding for COVID-19 vaccines. On the contrary, Republic Act No. 11494 (the Bayanihan to Recover as One Act) authorized the President to exercise necessary and proper powers for COVID-19 response, and waived the Phase IV trial requirement for vaccines recommended by the WHO or other internationally recognized health agencies. Executive Order No. 121 further allowed the FDA Director-General to issue Emergency Use Authorizations (EUAs), which precluded the need for completed clinical trials. The FDA had already granted an EUA for Sinovac on February 22, 2021.

Republic Act No. 11525 (the COVID-19 Vaccination Program Act of 2021) likewise exempted vaccine procurement from public bidding, allowing negotiated procurement under emergency cases. Given these laws, the Court found no ministerial duty to compel, and the contrary appeared: respondents had sufficient leeway to deviate from usual procedures.

Direct Resort to the Supreme Court Was Improper

The Court also noted that the petition should have been filed with the Regional Trial Court, not the Supreme Court. Under the doctrine of hierarchy of courts, parties must file petitions for extraordinary writs before lower courts unless special and important reasons exist. The petitioner's challenge to vaccine efficacy raised questions of fact, which the Supreme Court cannot resolve as it is not a trier of facts. None of the recognized exceptions to direct resort applied.

Practical Takeaways

• Presidential immunity is absolute during tenure. A sitting President cannot be sued in any proceeding, whether civil, criminal, or administrative, and regardless of whether the acts are personal or official.
• Mandamus only compels ministerial duties. Courts will not issue the writ to control discretionary acts, such as how officials respond to a public health crisis.
• Emergency laws can validly suspend usual procedures. R.A. 11494 and R.A. 11525 allowed expedited vaccine procurement without clinical trials or public bidding, subject to WHO recommendations and FDA EUAs.
• Respect the hierarchy of courts. Petitions for mandamus against government officials should generally be filed with the Regional Trial Court, not directly with the Supreme Court.
• Challenges to scientific judgments belong in proper forums. Questions about vaccine efficacy require factual evidence and are not appropriate for mandamus proceedings.

This article is general information and not legal advice. For your specific situation, consult a lawyer or ask ASG Legal AI.